Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p3301 has 253 genes in the original annotation. Currently, there are 147 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
6387	CXCL12	IRH \| PBSF \| SCYB12 \| SDF1 \| TLSF \| TPAR1	C-X-C motif chemokine ligand 12	10q11.1
240	ALOX5	5-LO \| 5-LOX \| 5LPG \| LOG5	arachidonate 5-lipoxygenase	10q11.2
29760	BLNK	AGM4 \| BASH \| BLNK-S \| LY57 \| SLP-65 \| SLP65 \| bca	B-cell linker	10q23.2-q23.33
51363	CHST15	BRAG \| GALNAC4S-6ST	carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15	10q26
960	CD44	CDW44 \| CSPG8 \| ECMR-III \| HCELL \| HUTCH-I \| IN \| LHR \| MC56 \| MDU2 \| MDU3 \| MIC4 \| Pgp1	CD44 molecule (Indian blood group)	11p13
133	ADM	AM \| PAMP	adrenomedullin	11p15.4
4046	LSP1	WP34 \| pp52	lymphocyte-specific protein 1	11p15.5
64231	MS4A6A	4SPAN3 \| 4SPAN3.2 \| CD20L3 \| CDA01 \| MS4A6 \| MST090 \| MSTP090	membrane spanning 4-domains A6A	11q12.1
7351	UCP2	BMIQ4 \| SLC25A8 \| UCPH	uncoupling protein 2 (mitochondrial, proton carrier)	11q13
330	BIRC3	AIP1 \| API2 \| CIAP2 \| HAIP1 \| HIAP1 \| MALT2 \| MIHC \| RNF49 \| c-IAP2	baculoviral IAP repeat containing 3	11q22
4312	MMP1	CLG \| CLGN	matrix metallopeptidase 1	11q22.3
3587	IL10RA	CD210 \| CD210a \| CDW210A \| HIL-10R \| IL-10R1 \| IL10R	interleukin 10 receptor subunit alpha	11q23
4837	NNMT	-	nicotinamide N-methyltransferase	11q23.1
6653	SORL1	C11orf32 \| LR11 \| LRP9 \| SORLA \| SorLA-1 \| gp250	sortilin-related receptor, L(DLR class) A repeats containing	11q23.2-q24.2
4256	MGP	GIG36 \| MGLAP \| NTI	matrix Gla protein	12p12.3
939	CD27	S152 \| S152. LPFS2 \| T14 \| TNFRSF7 \| Tp55	CD27 molecule	12p13
9976	CLEC2B	AICL \| CLECSF2 \| HP10085 \| IFNRG1	C-type lectin domain family 2 member B	12p13-p12
6515	SLC2A3	GLUT3	solute carrier family 2 member 3	12p13.3
9332	CD163	M130 \| MM130	CD163 molecule	12p13.3
920	CD4	CD4mut	CD4 molecule	12p13.31
22822	PHLDA1	DT1P1B11 \| PHRIP \| TDAG51	pleckstrin homology like domain family A member 1	12q15
241	ALOX5AP	FLAP	arachidonate 5-lipoxygenase activating protein	13q12
283537	SLC46A3	FKSG16	solute carrier family 46 member 3	13q12.3
26586	CKAP2	LB1 \| TMAP \| se20-10	cytoskeleton associated protein 2	13q14
12	SERPINA3	AACT \| ACT \| GIG24 \| GIG25	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3	14q32.1
5265	SERPINA1	A1A \| A1AT \| AAT \| PI \| PI1 \| PRO2275 \| alpha1AT	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1	14q32.1
7453	WARS	GAMMA-2 \| IFI53 \| IFP53	tryptophanyl-tRNA synthetase	14q32.31
771	CA12	CA-XII \| CAXII \| HsT18816 \| T18816	carbonic anhydrase XII	15q22
1543	CYP1A1	AHH \| AHRR \| CP11 \| CYP1 \| CYPIA1 \| P1-450 \| P450-C \| P450DX	cytochrome P450 family 1 subfamily A member 1	15q24.1
597	BCL2A1	ACC-1 \| ACC-2 \| ACC1 \| ACC2 \| BCL2L5 \| BFL1 \| GRS \| HBPA1	BCL2 related protein A1	15q24.3
1512	CTSH	ACC-4 \| ACC-5 \| ACC4 \| ACC5 \| CPSB	cathepsin H	15q25.1
11151	CORO1A	CLABP \| CLIPINA \| HCORO1 \| IMD8 \| TACO \| p57	coronin 1A	16p11.2
4501	MT1X	MT-1l \| MT1	metallothionein 1X	16q13
4502	MT2A	MT2	metallothionein 2A	16q13
3394	IRF8	H-ICSBP \| ICSBP \| ICSBP1 \| IMD32A \| IMD32B \| IRF-8	interferon regulatory factor 8	16q24.1
6355	CCL8	HC14 \| MCP-2 \| MCP2 \| SCYA10 \| SCYA8	C-C motif chemokine ligand 8	17q11.2
6347	CCL2	GDCF-2 \| HC11 \| HSMCR30 \| MCAF \| MCP-1 \| MCP1 \| SCYA2 \| SMC-CF	C-C motif chemokine ligand 2	17q11.2-q12
6352	CCL5	D17S136E \| RANTES \| SCYA5 \| SIS-delta \| SISd \| TCP228 \| eoCP	C-C motif chemokine ligand 5	17q12
10882	C1QL1	C1QRF \| C1QTNF14 \| CRF	complement component 1, q subcomponent-like 1	17q21
3487	IGFBP4	BP-4 \| HT29-IGFBP \| IBP4 \| IGFBP-4	insulin like growth factor binding protein 4	17q21.2
3838	KPNA2	IPOA1 \| QIP2 \| RCH1 \| SRP1-alpha \| SRP1alpha	karyopherin subunit alpha 2	17q24.2
9021	SOCS3	ATOD4 \| CIS3 \| Cish3 \| SOCS-3 \| SSI-3 \| SSI3	suppressor of cytokine signaling 3	17q25.3
11031	RAB31	Rab22B	RAB31, member RAS oncogene family	18p11.3
5055	SERPINB2	HsT1201 \| PAI \| PAI-2 \| PAI2 \| PLANH2	serpin peptidase inhibitor, clade B (ovalbumin), member 2	18q21.3
9244	CRLF1	CISS \| CISS1 \| CLF \| CLF-1 \| NR6 \| zcytor5	cytokine receptor-like factor 1	19p12
4125	MAN2B1	LAMAN \| MANB	mannosidase alpha class 2B member 1	19p13.2
54	ACP5	HPAP \| SPENCDI \| TRAP	acid phosphatase 5, tartrate resistant	19p13.2
3383	ICAM1	BB2 \| CD54 \| P3.58	intercellular adhesion molecule 1	19p13.2
1675	CFD	ADIPSIN \| ADN \| DF \| PFD	complement factor D (adipsin)	19p13.3
718	C3	AHUS5 \| ARMD9 \| ASP \| C3a \| C3b \| CPAMD1 \| HEL-S-62p	complement component 3	19p13.3-p13.2
5329	PLAUR	CD87 \| U-PAR \| UPAR \| URKR	plasminogen activator, urokinase receptor	19q13
7305	TYROBP	DAP12 \| KARAP \| PLOSL	TYRO protein tyrosine kinase binding protein	19q13.12
973	CD79A	IGA \| MB-1	CD79a molecule	19q13.2
348	APOE	AD2 \| APO-E \| LDLCQ5 \| LPG	apolipoprotein E	19q13.2
54855	FAM46C	-	family with sequence similarity 46 member C	1p12
963	CD53	MOX44 \| TSPAN25	CD53 molecule	1p13
7805	LAPTM5	CLAST6	lysosomal protein transmembrane 5	1p34
712	C1QA	-	complement component 1, q subcomponent, A chain	1p36.12
713	C1QB	-	complement component 1, q subcomponent, B chain	1p36.12
6279	S100A8	60B8AG \| CAGA \| CFAG \| CGLA \| CP-10 \| L1Ag \| MA387 \| MIF \| MRP8 \| NIF \| P8	S100 calcium binding protein A8	1q21
6280	S100A9	60B8AG \| CAGB \| CFAG \| CGLB \| L1AG \| LIAG \| MAC387 \| MIF \| MRP14 \| NIF \| P14	S100 calcium binding protein A9	1q21
962	CD48	BCM1 \| BLAST \| BLAST1 \| MEM-102 \| SLAMF2 \| hCD48 \| mCD48	CD48 molecule	1q21.3-q22
4332	MNDA	PYHIN3	myeloid cell nuclear differentiation antigen	1q22
2215	FCGR3B	CD16 \| CD16b \| FCG3 \| FCGR3 \| FCR-10 \| FCRIII \| FCRIIIb	Fc fragment of IgG receptor IIIb	1q23
2212	FCGR2A	CD32 \| CD32A \| CDw32 \| FCG2 \| FCGR2 \| FCGR2A1 \| FcGR \| IGFR2	Fc fragment of IgG receptor IIa	1q23
5743	PTGS2	COX-2 \| COX2 \| GRIPGHS \| PGG/HS \| PGHS-2 \| PHS-2 \| hCox-2	prostaglandin-endoperoxide synthase 2	1q25.2-q25.3
5997	RGS2	G0S8	regulator of G-protein signaling 2	1q31
1604	CD55	CR \| CROM \| DAF \| TC	CD55 molecule (Cromer blood group)	1q32
1116	CHI3L1	ASRT7 \| CGP-39 \| GP-39 \| GP39 \| HC-gp39 \| HCGP-3P \| YKL-40 \| YKL40 \| YYL-40 \| hCGP-39	chitinase 3 like 1	1q32.1
3055	HCK	JTK9 \| p59Hck \| p61Hck	HCK proto-oncogene, Src family tyrosine kinase	20q11-q12
3929	LBP	BPIFD2	lipopolysaccharide binding protein	20q11.23
5266	PI3	ESI \| SKALP \| WAP3 \| WFDC14 \| cementoin	peptidase inhibitor 3	20q13.12
4318	MMP9	CLG4B \| GELB \| MANDP2 \| MMP-9	matrix metallopeptidase 9	20q13.12
64092	SAMSN1	HACS1 \| NASH1 \| SASH2 \| SH3D6B \| SLy2	SAM domain, SH3 domain and nuclear localization signals 1	21q11
3689	ITGB2	CD18 \| LAD \| LCAMB \| LFA-1 \| MAC-1 \| MF17 \| MFI7	integrin subunit beta 2	21q22.3
51816	CECR1	ADA2 \| ADGF \| IDGFL \| PAN \| SNEDS	cat eye syndrome chromosome region, candidate 1	22q11.2
5880	RAC2	EN-7 \| Gx \| HSPC022 \| p21-Rac2	ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)	22q13.1
1439	CSF2RB	CD131 \| CDw131 \| IL3RB \| IL5RB \| SMDP5	colony stimulating factor 2 receptor beta common subunit	22q13.1
4689	NCF4	NCF \| P40PHOX \| SH3PXD4	neutrophil cytosolic factor 4	22q13.1
822	CAPG	AFCP \| HEL-S-66 \| MCP	capping actin protein, gelsolin like	2p11.2
65055	REEP1	C2orf23 \| HMN5B \| SPG31 \| Yip2a	receptor accessory protein 1	2p11.2
10797	MTHFD2	NMDMC	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase	2p13.1
6509	SLC1A4	ASCT1 \| SATT \| SPATCCM	solute carrier family 1 member 4	2p14
3553	IL1B	IL-1 \| IL1-BETA \| IL1F2	interleukin 1 beta	2q14
3557	IL1RN	DIRA \| ICIL-1RA \| IL-1RN \| IL-1ra \| IL-1ra3 \| IL1F3 \| IL1RA \| IRAP \| MVCD4	interleukin 1 receptor antagonist	2q14.2
7852	CXCR4	CD184 \| D2S201E \| FB22 \| HM89 \| HSY3RR \| LAP-3 \| LAP3 \| LCR1 \| LESTR \| NPY3R \| NPYR \| NPYRL \| NPYY3R \| WHIM \| WHIMS	C-X-C motif chemokine receptor 4	2q21
8942	KYNU	KYNUU	kynureninase	2q22.2
7130	TNFAIP6	TSG-6 \| TSG6	TNF alpha induced protein 6	2q23.3
5270	SERPINE2	GDN \| GDNPF \| PI-7 \| PI7 \| PN-1 \| PN1 \| PNI	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2	2q36.1
1230	CCR1	CD191 \| CKR-1 \| CKR1 \| CMKBR1 \| HM145 \| MIP1aR \| SCYAR1	C-C motif chemokine receptor 1	3p21
23166	STAB1	CLEVER-1 \| FEEL-1 \| FELE-1 \| FEX1 \| STAB-1	stabilin 1	3p21.1
729230	CCR2	CC-CKR-2 \| CCR-2 \| CCR2A \| CCR2B \| CD192 \| CKR2 \| CKR2A \| CKR2B \| CMKBR2 \| MCP-1-R	C-C motif chemokine receptor 2	3p21.31
10752	CHL1	CALL \| L1CAM2	cell adhesion molecule L1 like	3p26.1
23231	SEL1L3	Sel-1L3	SEL1L family member 3	4p15.2
2919	CXCL1	FSP \| GRO1 \| GROa \| MGSA \| MGSA-a \| NAP-3 \| SCYB1	C-X-C motif chemokine ligand 1	4q21
4283	CXCL9	CMK \| Humig \| MIG \| SCYB9 \| crg-10	C-X-C motif chemokine ligand 9	4q21
51316	PLAC8	C15 \| DGIC \| PNAS-144 \| onzin	placenta specific 8	4q21.22
6696	SPP1	BNSP \| BSPI \| ETA-1 \| OPN	secreted phosphoprotein 1	4q22.1
3426	CFI	AHUS3 \| ARMD13 \| C3BINA \| C3b-INA \| FI \| IF \| KAF	complement factor I	4q25
23657	SLC7A11	CCBR1 \| xCT	solute carrier family 7 member 11	4q28.3
5734	PTGER4	EP4 \| EP4R	prostaglandin E receptor 4	5p13.1
2533	FYB	ADAP \| PRO0823 \| SLAP-130 \| SLAP130	FYN binding protein	5p13.1
7060	THBS4	TSP-4 \| TSP4	thrombospondin 4	5q13
25816	TNFAIP8	GG2-1 \| MDC-3.13 \| NDED \| SCC-S2 \| SCCS2	TNF alpha induced protein 8	5q23.1
929	CD14	-	CD14 molecule	5q31.1
51237	MZB1	MEDA-7 \| PACAP \| pERp1	marginal zone B and B1 cell specific protein	5q31.2
972	CD74	DHLAG \| HLADG \| II \| Ia-GAMMA	CD74 molecule	5q32
1436	CSF1R	C-FMS \| CD115 \| CSF-1R \| CSFR \| FIM2 \| FMS \| HDLS \| M-CSF-R	colony stimulating factor 1 receptor	5q32
27242	TNFRSF21	BM-018 \| CD358 \| DR6	tumor necrosis factor receptor superfamily member 21	6p21.1
7941	PLA2G7	LDL-PLA2 \| LP-PLA2 \| PAFAD \| PAFAH	phospholipase A2 group VII	6p21.2-p12
629	CFB	AHUS4 \| ARMD14 \| BF \| BFD \| CFAB \| CFBD \| FB \| FBI12 \| GBG \| H2-Bf \| PBF2	complement factor B	6p21.3
3108	HLA-DMA	D6S222E \| DMA \| HLADM \| RING6	major histocompatibility complex, class II, DM alpha	6p21.3
3109	HLA-DMB	D6S221E \| RING7	major histocompatibility complex, class II, DM beta	6p21.3
3113	HLA-DPA1	DP(W3) \| DP(W4) \| HLA-DP1A \| HLADP \| HLASB \| PLT1	major histocompatibility complex, class II, DP alpha 1	6p21.3
3115	HLA-DPB1	DPB1 \| HLA-DP \| HLA-DP1B \| HLA-DPB	major histocompatibility complex, class II, DP beta 1	6p21.3
3117	HLA-DQA1	CD \| CELIAC1 \| DQ-A1 \| GSE \| HLA-DQA	major histocompatibility complex, class II, DQ alpha 1	6p21.3
3119	HLA-DQB1	CELIAC1 \| HLA-DQB \| IDDM1	major histocompatibility complex, class II, DQ beta 1	6p21.3
3122	HLA-DRA	HLA-DRA1 \| MLRW	major histocompatibility complex, class II, DR alpha	6p21.3
3123	HLA-DRB1	DRB1 \| DRw10 \| HLA-DR1B \| HLA-DRB \| SS1	major histocompatibility complex, class II, DR beta 1	6p21.3
8870	IER3	DIF-2 \| DIF2 \| GLY96 \| IEX-1 \| IEX-1L \| IEX1 \| PRG1	immediate early response 3	6p21.3
4050	LTB	TNFC \| TNFSF3 \| TNLG1C \| p33	lymphotoxin beta	6p21.3
3662	IRF4	LSIRF \| MUM1 \| NF-EM5 \| SHEP8	interferon regulatory factor 4	6p25.3
2162	F13A1	F13A	coagulation factor XIII A chain	6p25.3-p24.3
7128	TNFAIP3	A20 \| AISBL \| OTUD7C \| TNFA1P2	TNF alpha induced protein 3	6q23
6648	SOD2	IPOB \| MNSOD \| MVCD6	superoxide dismutase 2, mitochondrial	6q25.3
6424	SFRP4	FRP-4 \| FRPHE \| sFRP-4	secreted frizzled-related protein 4	7p14.1
3624	INHBA	EDF \| FRP	inhibin beta A	7p15-p13
54504	CPVL	HVLP	carboxypeptidase, vitellogenic like	7p15.1
3569	IL6	BSF-2 \| BSF2 \| CDF \| HGF \| HSF \| IFN-beta-2 \| IFNB2 \| IL-6	interleukin 6	7p21
10875	FGL2	T49 \| pT49	fibrinogen like 2	7q11.23
4034	LRCH4	LRN \| LRRN1 \| LRRN4 \| PP14183	leucine-rich repeats and calponin homology (CH) domain containing 4	7q22
10135	NAMPT	1110035O14Rik \| PBEF \| PBEF1 \| VF \| VISFATIN	nicotinamide phosphoribosyltransferase	7q22.3
1052	CEBPD	C/EBP-delta \| CELF \| CRP3 \| NF-IL6-beta	CCAAT/enhancer binding protein delta	8p11.2-p11.1
27299	ADAMDEC1	M12.219	ADAM-like, decysin 1	8p21.2
4481	MSR1	CD204 \| SCARA1 \| SR-A \| SRA \| phSR1 \| phSR2	macrophage scavenger receptor 1	8p22
1508	CTSB	APPS \| CPSB	cathepsin B	8p22
4067	LYN	JTK8 \| p53Lyn \| p56Lyn	LYN proto-oncogene, Src family tyrosine kinase	8q13
23643	LY96	ESOP-1 \| MD-2 \| MD2 \| ly-96	lymphocyte antigen 96	8q21.11
6503	SLA	SLA1 \| SLAP	Src-like-adaptor	8q24
10221	TRIB1	C8FW \| GIG-2 \| GIG2 \| SKIP1 \| TRB-1 \| TRB1	tribbles pseudokinase 1	8q24.13
51571	FAM49B	BM-009 \| L1	family with sequence similarity 49 member B	8q24.21
5079	PAX5	ALL3 \| BSAP	paired box 5	9p13
1306	COL15A1	-	collagen type XV alpha 1	9q21-q22
19	ABCA1	ABC-1 \| ABC1 \| CERP \| HDLDT1 \| TGD	ATP binding cassette subfamily A member 1	9q31.1
7076	TIMP1	CLGI \| EPA \| EPO \| HCI \| TIMP \| TIMP-1	TIMP metallopeptidase inhibitor 1	Xp11.3-p11.23
1536	CYBB	AMCBX2 \| CGD \| GP91-1 \| GP91-PHOX \| GP91PHOX \| IMD34 \| NOX2 \| p91-PHOX	cytochrome b-245, beta polypeptide	Xp21.1
6303	SAT1	DC21 \| KFSD \| KFSDX \| SAT \| SSAT \| SSAT-1	spermidine/spermine N1-acetyltransferase 1	Xp22.1